Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
   
Ask the Experts About

Opportunistic InfectionsOpportunistic Infections
           
Rollover images to visit our other forums!
  
  • Email Email
  • Glossary Glossary


New regime and PCP???
Nov 1, 2001

I am very allergic to Bactrim and Dapsone. I have been on Aerosolized Pentamidine for 5 years. I am about to add Retinovir to my Crixivan/Combivir regime at the suggestion of my ID consultant. My CD4 has been 350. My T helper cells are about 20%. Viral load has been undetectable for 5 years. We are discussing discontinuing my AP treatments. I have had PCP 5 years ago with CD4 count of 12. I am frankly afraid of the PCP. I am doing generally fairly well for someone infected for 17 years at age 51. Is there a major risk here?

Response from Dr. Feinberg

You can safely discontinue your AP prophylaxis treatments. With a total CD4 cell count of 350 and an undetectable viral load, your risk for recurrent PCP is close to zero. If, in the future your CD4 cells decline for some reason and are once again close to or below 200, then it would be reasonable to restart the AP. Don't worry, and celebrate every month when you would have gone for your AP treatment!


Previous
HPV and Abnormal Pap
Next
Scalp problems

  
  • Email Email
  • Glossary Glossary


 
 
Advertisement




Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement